{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:08:14Z","timestamp":1791986894731,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL131471"],"award-info":[{"award-number":["P01HL131471"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UG3HL147367"],"award-info":[{"award-number":["UG3HL147367"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01HD080642"],"award-info":[{"award-number":["P01HD080642"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI121135"],"award-info":[{"award-number":["R01AI121135"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0212"],"award-info":[{"award-number":["W81XWH-17-1-0212"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1132169"],"award-info":[{"award-number":["OPP1132169"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recombinant adeno-associated viruses (rAAVs) are currently considered the safest and most reliable gene delivery vehicles for human gene therapy. Three serotype capsids, AAV1, AAV2, and AAV9, have been approved for commercial use in patients, but they may not be\u00a0suitable for all therapeutic contexts. Here, we describe a novel capsid identified in a human clinical sample by high-throughput, long-read sequencing. The capsid, which we have named AAVv66, shares high sequence similarity with AAV2. We demonstrate that compared to AAV2, AAVv66 exhibits enhanced production yields, virion stability, and CNS transduction. Unique structural properties of AAVv66 visualized by cryo-EM at 2.5-\u00c5 resolution, suggest that critical residues at the three-fold protrusion and at the interface of the five-fold axis of symmetry likely contribute to the beneficial characteristics of AAVv66. Our findings underscore the potential of AAVv66 as a gene therapy vector.<\/jats:p>","DOI":"10.1038\/s41467-020-17047-1","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T10:03:57Z","timestamp":1593511437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Structural characterization of a novel human adeno-associated virus capsid with neurotropic properties"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1284-4182","authenticated-orcid":false,"given":"Hung-Lun","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-7747","authenticated-orcid":false,"given":"Anna B.","family":"Loveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoushka","family":"Lotun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Gessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7409-8344","authenticated-orcid":false,"given":"Phillip W. L.","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-717X","authenticated-orcid":false,"given":"Andrei A.","family":"Korostelev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0097-9012","authenticated-orcid":false,"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"17047_CR1","first-page":"2327","volume":"2","author":"N Muzyczka","year":"2001","unstructured":"Muzyczka, N. & Berns, K. Parvoviridae: the viruses and their replication. Fields Virol. 2, 2327\u20132359 (2001).","journal-title":"Fields Virol."},{"key":"17047_CR2","doi-asserted-by":"publisher","unstructured":"Wang, D., Tai, P. W. L. & Gao, G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/s41573-019-0012-9 (2019).","DOI":"10.1038\/s41573-019-0012-9"},{"key":"17047_CR3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.aaw2900","volume":"366","author":"PJ Ogden","year":"2019","unstructured":"Ogden, P. J., Kelsic, E. D., Sinai, S., Church, G. M. & Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design. Science 366, 1139\u20131143 (2019).","journal-title":"Science"},{"key":"17047_CR4","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1128\/JVI.02524-12","volume":"87","author":"B Venkatakrishnan","year":"2013","unstructured":"Venkatakrishnan, B. et al. Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking. J. Virol. 87, 4974\u20134984 (2013).","journal-title":"J. Virol."},{"key":"17047_CR5","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1128\/JVI.00580-07","volume":"81","author":"JC Grieger","year":"2007","unstructured":"Grieger, J. C., Johnson, J. S., Gurda-Whitaker, B., Agbandje-McKenna, M. & Samulski, R. J. Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2\/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions. J. Virol. 81, 7833\u20137843 (2007).","journal-title":"J. Virol."},{"key":"17047_CR6","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/JVI.79.4.2528-2540.2005","volume":"79","author":"S Bleker","year":"2005","unstructured":"Bleker, S., Sonntag, F. & Kleinschmidt, J. A. Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity. J. Virol. 79, 2528\u20132540 (2005).","journal-title":"J. Virol."},{"key":"17047_CR7","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1128\/JVI.07232-11","volume":"86","author":"MA DiMattia","year":"2012","unstructured":"DiMattia, M. A. et al. Structural insight into the unique properties of adeno-associated virus serotype 9. J. Virol. 86, 6947\u20136958 (2012).","journal-title":"J. Virol."},{"key":"17047_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.virol.2010.03.027","volume":"403","author":"TF Lerch","year":"2010","unstructured":"Lerch, T. F., Xie, Q. & Chapman, M. S. The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion. Virology 403, 26\u201336 (2010).","journal-title":"Virology"},{"key":"17047_CR9","doi-asserted-by":"crossref","first-page":"11187","DOI":"10.1128\/JVI.00867-13","volume":"87","author":"L Govindasamy","year":"2013","unstructured":"Govindasamy, L. et al. Structural insights into adeno-associated virus serotype 5. J. Virol. 87, 11187\u201311199 (2013).","journal-title":"J. Virol."},{"key":"17047_CR10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virol.2012.05.004","volume":"431","author":"DM McCraw","year":"2012","unstructured":"McCraw, D. M., O\u2019Donnell, J. K., Taylor, K. A., Stagg, S. M. & Chapman, M. S. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. Virology 431, 40\u201349 (2012).","journal-title":"Virology"},{"key":"17047_CR11","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1128\/JVI.77.20.11072-11081.2003","volume":"77","author":"A Kern","year":"2003","unstructured":"Kern, A. et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol. 77, 11072\u201311081 (2003).","journal-title":"J. Virol."},{"key":"17047_CR12","first-page":"9","volume":"5","author":"YS Tseng","year":"2014","unstructured":"Tseng, Y. S. & Agbandje-McKenna, M. Mapping the AAV capsid host antibody response toward the development of second generation gene delivery vectors. Front Immunol. 5, 9 (2014).","journal-title":"Front Immunol."},{"key":"17047_CR13","first-page":"357","volume":"2","author":"T Flotte","year":"1995","unstructured":"Flotte, T. & Carter, B. Adeno-associated virus vectors for gene therapy. Gene Ther. 2, 357\u2013362 (1995).","journal-title":"Gene Ther."},{"key":"17047_CR14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/mt.2011.287","volume":"20","author":"A Asokan","year":"2012","unstructured":"Asokan, A., Schaffer, D. V. & Samulski, R. J. The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 20, 699\u2013708 (2012).","journal-title":"Mol. Ther."},{"key":"17047_CR15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","volume":"21","author":"S Daya","year":"2008","unstructured":"Daya, S. & Berns, K. I. Gene therapy using adeno-associated virus vectors. Clin. Microbiol. Rev. 21, 583\u2013593 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"17047_CR16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nbt1182","volume":"24","author":"N Maheshri","year":"2006","unstructured":"Maheshri, N., Koerber, J. T., Kaspar, B. K. & Schaffer, D. V. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol. 24, 198 (2006).","journal-title":"Nat. Biotechnol."},{"key":"17047_CR17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/mt.2008.167","volume":"16","author":"JT Koerber","year":"2008","unstructured":"Koerber, J. T., Jang, J.-H. & Schaffer, D. V. DNA shuffling of adeno-associated virus yields functionally diverse viral progeny. Mol. Ther. 16, 1703\u20131709 (2008).","journal-title":"Mol. Ther."},{"key":"17047_CR18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymthe.2017.09.021","volume":"26","author":"NK Paulk","year":"2018","unstructured":"Paulk, N. K. et al. Bioengineered AAV capsids with combined high human liver transduction in vivo and unique humoral seroreactivity. Mol. Ther. 26, 289\u2013303 (2018).","journal-title":"Mol. Ther."},{"key":"17047_CR19","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1073\/pnas.0813207106","volume":"106","author":"L Yang","year":"2009","unstructured":"Yang, L. et al. A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Proc. Natl Acad. Sci. USA 106, 3946\u20133951 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17047_CR20","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","volume":"12","author":"E Zinn","year":"2015","unstructured":"Zinn, E. et al. In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector. Cell Rep. 12, 1056\u20131068 (2015).","journal-title":"Cell Rep."},{"key":"17047_CR21","unstructured":"Kelsic, E, Sinai, S, Ogden, P, Nowak, M. & Church, G. M. American Society of Gene and Cell Therapy. 26, Cell Press: Chicago, IL, 2018. ."},{"key":"17047_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1126\/science.1162986","volume":"323","author":"J Eid","year":"2009","unstructured":"Eid, J. et al. Real-time DNA sequencing from single polymerase molecules. Science 323, 133\u2013138 (2009).","journal-title":"Science"},{"key":"17047_CR23","unstructured":"Tai, P. W. L et al. American Society of Gene and Cell Therapy. 27, Molecular therapy: Washington, DC, 2019)."},{"key":"17047_CR24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/hum.2010.107","volume":"21","author":"LH Vandenberghe","year":"2010","unstructured":"Vandenberghe, L. H. et al. Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing. Hum. Gene Ther. 21, 1251\u20131257 (2010).","journal-title":"Hum. Gene Ther."},{"key":"17047_CR25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2011.08.011","volume":"420","author":"Q Xie","year":"2011","unstructured":"Xie, Q., Lerch, T. F., Meyer, N. L. & Chapman, M. S. Structure\u2013function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6). Virology 420, 10\u201319 (2011).","journal-title":"Virology"},{"key":"17047_CR26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2009.05.010","volume":"98","author":"LG Glushakova","year":"2009","unstructured":"Glushakova, L. G. et al. AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells. Mol. Genet. Metab. 98, 289\u2013299 (2009).","journal-title":"Mol. Genet. Metab."},{"key":"17047_CR27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.gt.3302527","volume":"12","author":"W Ding","year":"2005","unstructured":"Ding, W., Zhang, L., Yan, Z. & Engelhardt, J. Intracellular trafficking of adeno-associated viral vectors. Gene Ther. 12, 873 (2005).","journal-title":"Gene Ther."},{"key":"17047_CR28","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/mt.2015.174","volume":"23","author":"S Li","year":"2015","unstructured":"Li, S. et al. Efficient and targeted transduction of nonhuman primate liver with systemically delivered optimized AAV3B vectors. Mol. Ther. 23, 1867\u20131876 (2015).","journal-title":"Mol. Ther."},{"key":"17047_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/hgtb.2016.173","volume":"28","author":"J Ai","year":"2017","unstructured":"Ai, J., Ibraheim, R., Tai, P. W. & Gao, G. A scalable and accurate method for quantifying vector genomes of recombinant adeno-associated viruses in crude lysate. Hum. Gene Ther. Methods 28, 139\u2013147 (2017).","journal-title":"Hum. Gene Ther. Methods"},{"key":"17047_CR30","first-page":"1209","volume":"2","author":"G Gao","year":"2012","unstructured":"Gao, G. & Sena-Esteves, M. Introducing genes into mammalian cells: viral vectors. Mol. Cloning 2, 1209\u20131313 (2012).","journal-title":"Mol. Cloning"},{"key":"17047_CR31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrd.2018.110","volume":"17","author":"BE Deverman","year":"2018","unstructured":"Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M. & Sah, D. W. Y. Gene therapy for neurological disorders: progress and prospects. Nat. Rev. Drug Discov. 17, 641\u2013659 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"17047_CR32","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao, G. et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381\u20136388 (2004).","journal-title":"J. Virol."},{"key":"17047_CR33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1099\/0022-1317-83-5-973","volume":"83","author":"A Girod","year":"2002","unstructured":"Girod, A. et al. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J. Gen. Virol. 83, 973\u2013978 (2002).","journal-title":"J. Gen. Virol."},{"key":"17047_CR34","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/JVI.03017-12","volume":"87","author":"ED Horowitz","year":"2013","unstructured":"Horowitz, E. D. et al. Biophysical and ultrastructural characterization of adeno-associated virus capsid uncoating and genome release. J. Virol. 87, 2994\u20133002 (2013).","journal-title":"J. Virol."},{"key":"17047_CR35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ymthe.2017.04.001","volume":"25","author":"S Pacouret","year":"2017","unstructured":"Pacouret, S. et al. AAV-ID: a rapid and robust assay for batch-to-batch consistency evaluation of AAV preparations. Mol. Ther. 25, 1375\u20131386 (2017).","journal-title":"Mol. Ther."},{"key":"17047_CR36","volume":"4","author":"Y-B Hu","year":"2015","unstructured":"Hu, Y.-B., Dammer, E. B., Ren, R.-J. & Wang, G. The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration. Transl. Neurodegener. 4, 18 (2015).","journal-title":"Transl. Neurodegener."},{"key":"17047_CR37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.virol.2005.09.030","volume":"345","author":"C Ros","year":"2006","unstructured":"Ros, C., Baltzer, C., Mani, B. & Kempf, C. Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability. Virology 345, 137\u2013147 (2006).","journal-title":"Virology"},{"key":"17047_CR38","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1073\/pnas.162250899","volume":"99","author":"Q Xie","year":"2002","unstructured":"Xie, Q. et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl Acad. Sci. USA 99, 10405\u201310410 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17047_CR39","doi-asserted-by":"crossref","first-page":"11556","DOI":"10.1128\/JVI.01536-06","volume":"80","author":"L Govindasamy","year":"2006","unstructured":"Govindasamy, L. et al. Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J. Virol. 80, 11556\u201311570 (2006).","journal-title":"J. Virol."},{"key":"17047_CR40","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1128\/JVI.01304-07","volume":"81","author":"H-J Nam","year":"2007","unstructured":"Nam, H.-J. et al. Structure of adeno-associated virus serotype 8, a gene therapy vector. J. Virol. 81, 12260\u201312271 (2007).","journal-title":"J. Virol."},{"key":"17047_CR41","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.1128\/JVI.01235-10","volume":"84","author":"R Ng","year":"2010","unstructured":"Ng, R. et al. Structural characterization of the dual glycan binding adeno-associated virus serotype 6. J. Virol. 84, 12945\u201312957 (2010).","journal-title":"J. Virol."},{"key":"17047_CR42","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","volume":"72","author":"C Summerford","year":"1998","unstructured":"Summerford, C. & Samulski, R. J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438\u20131445 (1998).","journal-title":"J. Virol."},{"key":"17047_CR43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2011.08.011","volume":"420","author":"Q Xie","year":"2011","unstructured":"Xie, Q., Lerch, T. F., Meyer, N. L. & Chapman, M. S. Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6). Virology 420, 10\u201319 (2011).","journal-title":"Virology"},{"key":"17047_CR44","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/mt.2016.84","volume":"24","author":"SR Choudhury","year":"2016","unstructured":"Choudhury, S. R. et al. In vivo selection yields AAV-B1 capsid for central nervous system and muscle gene therapy. Mol. Ther. 24, 1247\u20131257 (2016).","journal-title":"Mol. Ther."},{"key":"17047_CR45","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1128\/JVI.00076-06","volume":"80","author":"L Perabo","year":"2006","unstructured":"Perabo, L. et al. Heparan sulfate proteoglycan binding properties of adeno-associated virus retargeting mutants and consequences for their in vivo tropism. J. Virol. 80, 7265\u20137269 (2006).","journal-title":"J. Virol."},{"key":"17047_CR46","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","volume":"4","author":"O Devinsky","year":"2018","unstructured":"Devinsky, O. et al. Epilepsy. Nat. Rev. Dis. Prim. 4, 18024 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"17047_CR47","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1523\/JNEUROSCI.1143-18.2019","volume":"39","author":"A Snowball","year":"2019","unstructured":"Snowball, A. et al. Epilepsy gene therapy using an engineered potassium channel. J. Neurosci. 39, 3159\u20133169 (2019).","journal-title":"J. Neurosci."},{"key":"17047_CR48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJM200108023450501","volume":"345","author":"S Wiebe","year":"2001","unstructured":"Wiebe, S. et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N. Engl. J. Med. 345, 311\u2013318 (2001).","journal-title":"N. Engl. J. Med"},{"key":"17047_CR49","doi-asserted-by":"crossref","first-page":"e0225206","DOI":"10.1371\/journal.pone.0225206","volume":"14","author":"Q Huang","year":"2019","unstructured":"Huang, Q. et al. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS ONE 14, e0225206 (2019).","journal-title":"PLoS ONE"},{"key":"17047_CR50","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/JVI.75.4.1824-1833.2001","volume":"75","author":"A-M Douar","year":"2001","unstructured":"Douar, A.-M., Poulard, K., Stockholm, D. & Danos, O. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation. J. Virol. 75, 1824\u20131833 (2001).","journal-title":"J. Virol."},{"key":"17047_CR51","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1128\/JVI.01415-13","volume":"87","author":"V Rayaprolu","year":"2013","unstructured":"Rayaprolu, V. et al. Comparative analysis of adeno-associated virus capsid stability and dynamics. J. Virol. 87, 13150\u201313160 (2013).","journal-title":"J. Virol."},{"key":"17047_CR52","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/brain\/awy126","volume":"141","author":"J Tordo","year":"2018","unstructured":"Tordo, J. et al. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency. Brain 141, 2014\u20132031 (2018).","journal-title":"Brain"},{"key":"17047_CR53","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1128\/JVI.79.23.14781-14792.2005","volume":"79","author":"CL Chen","year":"2005","unstructured":"Chen, C. L. et al. Molecular characterization of adeno-associated viruses infecting children. J. Virol. 79, 14781\u201314792 (2005).","journal-title":"J. Virol."},{"key":"17047_CR54","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at: https:\/\/arxiv.org\/abs\/1303.3997 (2013)."},{"key":"17047_CR55","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","volume":"32","author":"RC Edgar","year":"2004","unstructured":"Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792\u20131797 (2004).","journal-title":"Nucleic Acids Res"},{"key":"17047_CR56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/molbev\/msp259","volume":"27","author":"M Gouy","year":"2010","unstructured":"Gouy, M., Guindon, S. & Gascuel, O. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27, 221\u2013224 (2010).","journal-title":"Mol. Biol. Evol."},{"key":"17047_CR57","doi-asserted-by":"publisher","unstructured":"Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkz239 (2019).","DOI":"10.1093\/nar\/gkz239"},{"key":"17047_CR58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12033-015-9899-5","volume":"58","author":"A Rashnonejad","year":"2016","unstructured":"Rashnonejad, A., Chermahini, G. A., Li, S., Ozkinay, F. & Gao, G. Large-scale production of adeno-associated viral vector serotype-9 carrying the human survival motor neuron gene. Mol. Biotechnol. 58, 30\u201336 (2016).","journal-title":"Mol. Biotechnol."},{"key":"17047_CR59","doi-asserted-by":"crossref","first-page":"e35383","DOI":"10.7554\/eLife.35383","volume":"7","author":"T Grant","year":"2018","unstructured":"Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for single-particle image processing. Elife 7, e35383 (2018).","journal-title":"Elife"},{"key":"17047_CR60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"17047_CR61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","volume":"199","author":"R Calcedo","year":"2009","unstructured":"Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J. & Wilson, J. M. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J. Infect. Dis. 199, 381\u2013390 (2009).","journal-title":"J. Infect. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17047-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17047-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T23:53:25Z","timestamp":1670284405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17047-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17047"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17047-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"assertion":[{"value":"8 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.G. is a scientific co-founder of Voyager Therapeutics and holds equity in the company. G.G. is an inventor on patents with potential royalties licensed to Voyager Therapeutics and other biopharmaceutical companies. G.G. and D.J.G. are scientific co-founders of Aspa Therapeutics Inc., and hold equity in the company. G.G. and D.J.G. are inventors on patents with potential royalties licensed to Aspa Therapeutics Inc., and other biopharmaceutical companies. Remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3279"}}